Target intelligence / Profile preview

CD8-positive T Cell (CTL)

Target
CTL
Molecular classification
T cell, Lymphocyte, Immune cell
01

Overview

CD8-positive T cells, also known as cytotoxic T lymphocytes (CTLs), are a subset of T cells critical for cell-mediated immunity. They recognize and eliminate infected or malignant cells through direct cytotoxicity and cytokine secretion. Their function is essential for defense against intracellular pathogens and tumors, but dysregulation can lead to autoimmune diseases or other immune-related disorders.

Other names
Cytotoxic T LymphocyteCD8+ T cellCD8 T cell
02

Mechanism of action

CD8+ T cells recognize and kill infected or malignant cells by releasing cytotoxic granules containing perforin and granzymes, or by inducing apoptosis through Fas-FasL interaction. They also secrete cytokines like IFN-gamma and TNF-alpha to modulate the immune response.

03

Biological functions

Cell-mediated immunityCytotoxicityImmune responseAntiviral defenseAntitumor defenseCytokine secretion
04

Disease associations

Viral infectionCancerAutoimmune diseaseImmunodeficiency
05

Safety considerations

Cytokine release syndromeAutoimmunityGraft-versus-host diseaseImmune-related adverse events (irAEs) associated with checkpoint inhibitors
06

Interacting drugs

Immunosuppressants (e.g., Cyclosporine, Tacrolimus)

3 more in the full profile.

07

Biomarkers

CD8 expression levelCD62LCCR7CD45RACD27CD28KLRG1CD57PD-1CTLA-4Tim-3Lag-3IFN-gammaTNF-alpha

Beyond the preview

Go deeper on CD8-positive T Cell (CTL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD8-positive T Cell (CTL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call